Surfactant lavage treatment in a model of respiratory distress syndrome.
Cochrane
C G
CG
Department of Immunology, The Scripps Research Institute, La Jolla, CA 92037, USA. cochrane@scripps.edu
Revak
S D
SD
D000818:Animals; D018893:Bronchoalveolar Lavage; D036341:Intercellular Signaling Peptides and Proteins; D008070:Lipopolysaccharides / Q000009:adverse effects; D010455:Peptides / Q000008:administration & dosage*; D011663:Pulmonary Surfactants / Q000008:administration & dosage*; D011817:Rabbits; D012128:Respiratory Distress Syndrome / Q000209:etiology / Q000628:therapy*
D036341:Intercellular Signaling Peptides and Proteins; C097558:KL4 surfactant; D008070:Lipopolysaccharides; D010455:Peptides; D011663:Pulmonary Surfactants